A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Update Il y a 4 ans
Reference: NCT00088270

Woman and Man

Extract

Multi-center, randomized Phase II study to evaluate the efficacy and safety of OSI-7904Lversus 5 FU/LV in biliary tract cancer.


Inclusion criteria

  • Locally Advanced or Metastatic Adenoca of the Biliary Tract


Links